Background/Aims: Patients who suffer from Dejerine-Roussy syndrome commonly experience severe poststroke hemibody pain which has historically been attributed to thalamic lesions. Despite pharmacological treatment, a significant proportion of the population is resistant to traditional therapy. Deep brain stimulation is often appropriate for the treatment of resistant populations. In this review we aim to summarize the targets that are used to treat Dejerine-Roussy syndrome and provide insight into their clinical efficacy. Methods: In reviewing the literature, we defined stimulation success as achievement of a minimum of 50% pain relief. Results: Contemporary targets for deep brain stimulation are the ventral posterior medial/ventral posterior lateral thalamic nuclei, periaqueductal/periventricular gray matter, the ventral striatum/anterior limb of the internal capsule, left centromedian thalamic nuclei, the nucleus ventrocaudalis parvocellularis internis, and the posterior limb of the internal capsule. Conclusions: Due to technological advancements in deep brain stimulation, its therapeutic effects must be reevaluated. Despite a lack of controlled evidence, deep brain stimulation has been effectively used as a therapeutic in clinical pain management. Further clinical investigation is needed to definitively evaluate the therapeutic efficacy of deep brain stimulation in treating the drug-resistant patient population.

Keywords:
Deep brain stimulation, Neuropathic pain, Dejerine-Roussy syndrome, Poststroke pain, Stroke
1.
Henry JL, Lalloo C, Yashpal K: Central poststroke pain: an abstruse outcome. Pain Res Manag 2008;13:41-49.
2.
Kumar B, et al: Central poststroke pain: a review of pathophysiology and treatment. Anesth Analg 2009;108:1645-1657.
3.
Plow EB, Malone DA Jr, Machado A: Deep brain stimulation of the ventral striatum/anterior limb of the internal capsule in thalamic pain syndrome: study protocol for a pilot randomized controlled trial. Trials 2013;14:241.
4.
Flaster M, et al: Central poststroke pain: current diagnosis and treatment. Top Stroke Rehabil 2013;20:116-123.
5.
Oh H, Seo W: A comprehensive review of central post-stroke pain. Pain Manag Nurs 2015;16:804-818.
6.
Hong JH, et al: Injury of the spino-thalamo-cortical pathway is necessary for central post-stroke pain. Eur Neurol 2010;64:163-168.
7.
Tasker RR, Vilela Filho O: Deep brain stimulation for neuropathic pain. Stereotact Funct Neurosurg 1995;65:122-124.
8.
Kumar A, et al: Central poststroke pain can occur with normal sensation. Clin J Pain 2016;32:955-960.
9.
Klit H, et al: Early evoked pain or dysesthesia is a predictor of central poststroke pain. Pain 2014;155:2699-2706.
10.
Déjerine J, Roussy G: Le syndrome thalamique. Rev Neurol (Paris) 1906, pp 521-532.
11.
Nandi D, et al: Thalamic field potentials in chronic central pain treated by periventricular gray stimulation - a series of eight cases. Pain 2003;101:97-107.
12.
Hansen AP, et al: Pain following stroke: a prospective study. Eur J Pain 2012;16:1128-1136.
13.
Andersen G, et al: Incidence of central post-stroke pain. Pain 1995;61:187-193.
14.
Segatore M: Understanding central post-stroke pain. J Neurosci Nurs 1996;28:28-35.
15.
Sahin-Onat S, et al: The effects of central post-stroke pain on quality of life and depression in patients with stroke. J Phys Ther Sci 2016;28:96-101.
16.
Kim JH, et al: Lesions limited to the human thalamic principal somatosensory nucleus (ventral caudal) are associated with loss of cold sensations and central pain. J Neurosci 2007;27:4995-5004.
17.
Morishita T, Inoue T: Brain stimulation therapy for central post-stroke pain from a perspective of interhemispheric neural network remodeling. Front Hum Neurosci 2016;10:166.
18.
Moisset X, Bouhassira D: Brain imaging of neuropathic pain. Neuroimage 2007;37(suppl 1):S80-S88.
19.
Gopalakrishnan R, et al: Pain anticipatory phenomena in patients with central poststroke pain: a magnetoencephalography study. J Neurophysiol 2016;116:1387-1395.
20.
Shih HC, Kuan YH, Shyu BC: Targeting brain-derived neurotrophic factor in the medial thalamus for the treatment of central poststroke pain in a rodent model. Pain 2017;158:1302-1313.
21.
Hosomi K, Seymour B, Saitoh Y: Modulating the pain network - neurostimulation for central poststroke pain. Nat Rev Neurol 2015;11:290-299.
22.
Takatsuru Y, et al: Neuronal circuit remodeling in the contralateral cortical hemisphere during functional recovery from cerebral infarction. J Neurosci 2009;29:10081-10086.
23.
Siegfried J, Lazorthes Y, Sedan R: Indications and ethical considerations of deep brain stimulation. Acta Neurochir Suppl (Wien) 1980;30:269-274.
24.
Wilkins RH, Brody IA: The thalamic syndrome. Arch Neurol 1969;20:559-562.
25.
Ryder S-A, Stannard CF: Treatment of chronic pain: antidepressant, antiepileptic and antiarrhythmic drugs. Contin Educ Anaesth Crit Care Pain 2005;5:18-21.
26.
Agnew DC, Goldberg VD: A brief trial of phenytoin therapy for thalamic pain. Bull Los Angeles Neurol Soc 1976;41:9-12.
27.
Vestergaard K, Jansen TS: Treatment of central post stroke pain with selective serotonin reuptake inhibitor. Eur J Neurol 1996;3:169.
28.
Attal N, et al: Effects of IV morphine in central pain: a randomized placebo-controlled study. Neurology 2002;58:554-563.
29.
Canavero S, Bonicalzi V, Paolotti R: Lack of effect of topiramate for central pain. Neurology 2002;58:831-832.
30.
Serpell MG; Neuropathic Pain Study Group: Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial. Pain 2002;99:557-566.
31.
Takahashi Y, Hashimoto K, Tsuji S: Successful use of zonisamide for central poststroke pain. J Pain 2004;5:192-194.
32.
Verma V, Singh N, Singh Jaggi A: Pregabalin in neuropathic pain: evidences and possible mechanisms. Curr Neuropharmacol 2014;12:44-56.
33.
Kalita J, Chandra S, Misra UK: Pregabalin and lamotrigine in central poststroke pain: a pilot study. Neurol India 2017;65:506-511.
34.
Coffey RJ: Deep brain stimulation for chronic pain: results of two multicenter trials and a structured review. Pain Med 2001;2:183-192.
35.
Rezaei Haddad A, Ughratdar I, Ashkan K: A single thalamic target for deep brain stimulation to treat hemi-body pain syndrome. Acta Neurochir 2015;157:1519-1523.
36.
Kelly ML, et al: Barriers to investigator-initiated deep brain stimulation and device research. Neurology 2014;82:1465-1473.
37.
Alves RV, Asfora WT: Deep brain stimulation for Dejerine-Roussy syndrome: case report. Minim Invasive Neurosurg 2011;54:183-186.
38.
Papuc E, et al: Reduction of thalamic tremor with deep brain stimulation performed for post stroke chronic central pain. Ann Agric Environ Med 2013;1:45-47.
39.
Delgado JM, Hamlin H, Chapman WP: Technique of intracranial electrode implacement for recording and stimulation and its possible therapeutic value in psychotic patients. Confin Neurol 1952;12:315-319.
40.
Mazars GJ: Intermittent stimulation of nucleus ventralis posterolateralis for intractable pain. Surg Neurol 1975;4:93-95.
41.
Richardson DE, Akil H: Pain reduction by electrical brain stimulation in man. 1. Acute administration in periaqueductal and periventricular sites. J Neurosurg 1977;47:178-183.
42.
Bittar RG, et al: Deep brain stimulation for pain relief: a meta-analysis. J Clin Neurosci 2005;12:515-519.
43.
Kovanlikaya I, Heier L, Kaplitt M: Treatment of chronic pain: diffusion tensor imaging identification of the ventroposterolateral nucleus confirmed with successful deep brain stimulation. Stereotact Funct Neurosurg 2014;92:365-371.
44.
Pereira EA, Aziz TZ: Neuropathic pain and deep brain stimulation. Neurotherapeutics 2014;11:496-507.
45.
Boccard SG, Pereira EA, Aziz TZ: Deep brain stimulation for chronic pain. J Clin Neurosci 2015;22:1537-1543.
46.
Boccard SG, et al: Tractography study of deep brain stimulation of the anterior cingulate cortex in chronic pain: key to improve the targeting. World Neurosurg 2016;86:361-370.e1-e3.
47.
Casquero-Veiga M, et al: Response to deep brain stimulation in three brain targets with implications in mental disorders: a PET study in rats. PLoS One 2016;11:e0168689.
48.
Marchand S, et al: Analgesic and placebo effects of thalamic stimulation. Pain 2003;105:481-488.
49.
Hamani C, et al: Deep brain stimulation for chronic neuropathic pain: long-term outcome and the incidence of insertional effect. Pain 2006;125:188-196.
50.
Cruccu G, et al: EAN guidelines on central neurostimulation therapy in chronic pain conditions. Eur J Neurol 2016;23:1489-1499.
51.
Lempka SF, et al: Randomized clinical trial of deep brain stimulation for poststroke pain. Ann Neurol 2017;81:653-663.
52.
Kumar K, Toth C, Nath RK: Deep brain stimulation for intractable pain: a 15-year experience. Neurosurgery 1997;40:736-746, discussion 746-747.
53.
Levy R, Deer TR, Henderson J: Intracranial neurostimulation for pain control: a review. Pain Physician 2010;13:157-165.
54.
Franzini A, et al: Long-term chronic stimulation of internal capsule in poststroke pain and spasticity: case report, long-term results and review of the literature. Stereotact Funct Neurosurg 2008;86:179-183.
55.
Adams JE, Hosobuchi Y, Fields HL: Stimulation of internal capsule for relief of chronic pain. J Neurosurg 1974;41:740-744.
56.
Dieckmann G, Witzmann A: Initial and long-term results of deep brain stimulation for chronic intractable pain. Appl Neurophysiol 1982;45:167-172.
57.
Hosobuchi Y: Subcortical electrical stimulation for control of intractable pain in humans: report of 122 cases (1970-1984). J Neurosurg 1986;64:543-553.
58.
Levy RM, Lamb S, Adams JE: Treatment of chronic pain by deep brain stimulation: long term follow-up and review of the literature. Neurosurgery 1987;21:885-893.
59.
Rasche D, et al: Deep brain stimulation for the treatment of various chronic pain syndromes. Neurosurg Focus 2006;21:E8.
60.
Boccard SG, et al: Long-term outcomes of deep brain stimulation for neuropathic pain. Neurosurgery 2013;72:221-230, discussion 231.
61.
Owen SL, et al: Deep brain stimulation for the alleviation of post-stroke neuropathic pain. Pain 2006;120:202-206.
62.
Young RF, et al: Release of beta-endorphin and methionine-enkephalin into cerebrospinal fluid during deep brain stimulation for chronic pain: effects of stimulation locus and site of sampling. J Neurosurg 1993;79:816-825.
63.
Hosobuchi Y, Adams JE, Rutkin B: Chronic thalamic and internal capsule stimulation for the control of central pain. Surg Neurol 1975;4:91-92.
64.
Hosobuchi Y, et al: Stimulation of human periaqueductal gray for pain relief increases immunoreactive beta-endorphin in ventricular fluid. Science 1979;203:279-281.
65.
Yamamoto T, et al: Pharmacological classification of central post-stroke pain: comparison with the results of chronic motor cortex stimulation therapy. Pain 1997;72:5-12.
66.
Iranami H, Yamazaki A, Hatano Y: Tramadol challenge for relief of intractable central poststroke pain. Mayo Clin Proc 2006;81:566.
67.
Sims-Williams H, et al: Deep brain stimulation of the periaqueductal gray releases endogenous opioids in humans. Neuroimage 2017;146:833-842.
68.
Ma QP, Han JS: Neurochemical studies on the mesolimbic circuitry of antinociception. Brain Res 1991;566:95-102.
69.
Ma QP, Shi YS, Han JS: Further studies on interactions between periaqueductal gray, nucleus accumbens and habenula in antinociception. Brain Res 1992;583:292-295.
70.
Lorenz J, Minoshima S, Casey KL: Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain 2003;126:1079-1091.
71.
Mallory GW, et al: The nucleus accumbens as a potential target for central poststroke pain. Mayo Clin Proc 2012;87:1025-1031.
72.
Morishita T, et al: Smile without euphoria induced by deep brain stimulation: a case report. Neurocase 2015;21:674-678.
73.
Schmahmann JD: Vascular syndromes of the thalamus. Stroke 2003;34:2264-2278.
74.
Zrinzo L, et al: Reducing hemorrhagic complications in functional neurosurgery: a large case series and systematic literature review. J Neurosurg 2012;116:84-94.
75.
Son BC, et al: Simultaneous trial of deep brain and motor cortex stimulation in chronic intractable neuropathic pain. Stereotact Funct Neurosurg 2014;92:218-226.
76.
Boccard SG, et al: Targeting the affective component of chronic pain: a case series of deep brain stimulation of the anterior cingulate cortex. Neurosurgery 2014;74:628-635, discussion 635-637.
77.
Boccard SG, et al: Deep brain stimulation of the anterior cingulate cortex: targeting the affective component of chronic pain. Neuroreport 2014;25:83-88.
78.
Richardson DE: Deep brain stimulation for the relief of chronic pain. Neurosurg Clin N Am 1995;6:135-144.
79.
Namba S, et al: Electrical stimulation of the posterior limb of the internal capsule for treatment of thalamic pain. Appl Neurophysiol 1984;47:137-148.
80.
Laterre EC, De Volder AG, Goffinet AM: Brain glucose metabolism in thalamic syndrome. J Neurol Neurosurg Psychiatry 1988;51:427-428.
81.
Willoch F, et al: Central poststroke pain and reduced opioid receptor binding within pain processing circuitries: a [11C]diprenorphine PET study. Pain 2004;108:213-220.
82.
Maarrawi J, et al: Differential brain opioid receptor availability in central and peripheral neuropathic pain. Pain 2007;127:183-194.
83.
Leijon G, Boivie J: Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine. Pain 1989;36:27-36.
84.
Helmchen C, et al: Disappearance of central thalamic pain syndrome after contralateral parietal lobe lesion: implications for therapeutic brain stimulation. Pain 2002;98:325-330.
85.
Honey CM, Tronnier VM, Honey CR: Deep brain stimulation versus motor cortex stimulation for neuropathic pain: a minireview of the literature and proposal for future research. Comput Struct Biotechnol J 2016;14:234-237.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.